Article
Curative Cell and Gene Therapy for Osteogenesis Imperfecta
1 Dec 2020
Abstract excerpt
Osteogenesis imperfecta (OI) describes a series of genetic bone fragility disorders that can have a substantive impact on patient quality of life. The multidisciplinary approach to management of children and adults with OI primarily involves the administration of antiresorptive medication, allied health (physiotherapy and occupational therapy), and orthopedic surgery. However, advances in gene editing technology...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
